These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Management of superficial transitional cell carcinoma of the bladder.
    Author: Fleischmann J, Goldberg G.
    Journal: Semin Urol; 1993 Nov; 11(4):193-204. PubMed ID: 8290825.
    Abstract:
    Intravesical therapy for the treatment of existing bladder cancer or for prophylaxis of recurrent disease should be chosen according to the stage of transitional-cell cancer. Papillary disease (stages Ta, T1) may be treated effectively with either an alkylating agent or with BCG. BCG is the agent of choice for the treatment of Tis, provided that the treatment course includes 12 weekly and 12 monthly instillations.
    [Abstract] [Full Text] [Related] [New Search]